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Synthesis of a-L-fucopyranoside-presenting glycoclusters and 
investigation of their interaction with Photorhabdus asymbiotica 
lectin (PHL) 
Gita Jančaříková,[a,b] Mihály Herczeg,[c] Eva Fujdiarová,[b] Josef Houser,[a,b] Katalin E. Kövér,[d] Anikó 
Borbás,*[c] Michaela Wimmerová*[a,b,e] and Magdolna Csávás*[c] 
Dedicated to Professor Pál Herczegh on the occasion of his 70th birthday.
Abstract: Photorhabdus asymbiotica is a gram-negative bacterium 
that is not only as effective an insect pathogen as other members of 
the genus, but it also causes serious diseases in humans. The 
recently identified lectin PHL from P. asymbiotica verifiably 
modulates an immune response of humans and insects, which 
supports the idea that the lectin might play an important role in the 
host-pathogen interaction. Dimeric PHL contains up to seven L-
fucose specific binding sites per monomer, and in order to target 
multiple binding sites of PHL, a-L-fucoside-containing di-, tri- and 
tetravalent glycoclusters were synthesized. Methyl gallate and 
pentaerythritol were chosen as multivalent scaffolds, and the 
fucoclusters were built from the above-mentioned cores by coupling 
with different oligoethylene bridges and propargyl a-L-fucosides 
using 1,3-dipolar azide-alkyne cycloaddition. The interaction 
between fucoside derivates and PHL was investigated by several 
biophysical and biological methods, ITC and SPR measurements, 
hemagglutination inhibition assay and an investigation of bacterial 
aggregation properties were carried out. Moreover, details of the 
interaction between PHL and propargyl a-L-fucoside as a monomer 
unit were revealed using X-ray crystallography. Besides this, the 
interaction with multivalent compounds was studied by NMR 
techniques. The newly synthesized multivalent fucoclusters proved 
to be up to several orders of magnitude better ligands than the 
natural ligand, L-fucose. 
Introduction 
Photorhabdus asymbiotica together with another three species 
(P. luminescens, P. temperata and P. heterorhabditis) belongs 
to the Photorhabdus genus – entomopathogenic bacteria 
forming a symbiotic relationship with nematodes from the genus 
Heterorhabditis. Unlike other Photorhabdus species, P. 
asymbiotica is unique in its ability to act as an emerging human 
pathogen. It causes invasive soft tissue infections that are 
difficult to treat locally, and disseminated bacteraemic disease 
characterized by multifocal skin and soft tissue abscesses.[1–4] 
Analysis of the P. asymbiotica genome identified the 
fucose/galactose-binding lectin PHL.[5] It was revealed that PHL 
has the ability to act as a host-cell recognizing agent through 
interacting with the haemolymph of Galleria mellonella (order 
Lepidoptera, family Pyralidae) and human blood components. 
Therefore, PHL could be considered to be a usable therapeutic 
target. 
The soluble lectin PHL forms a seven-bladed b-propeller 
assembling into a homo-dimer with an inter-subunit disulphide 
bridge. The crystal structure of the complex with different ligands 
demonstrated the existence of two sets of binding sites per 
monomer with preferences for L-fucose and D-galactose, 
respectively. Biophysical studies show an affinity of PHL mainly 
for a-L-fucosides over other tested ligands. Recent analysis of 
PHL/Me-a-L-Fuc complexes revealed up to seven potential 
fucose-binding sites per PHL monomer, forming a circle.[5] On 
the basis of biological tests, a specific agglutination of type O 
human red blood cells (RBCs) was observed as well as 
interaction with all types of RBCs through a-fucoside. These 
outcomes suggest that this lectin could be also directly involved 
in the adhesion to host cells. This leads to the need for glyco-
inhibitors which can strongly bind to the lectin to compete with 
and disrupt host-lectin interaction during the first step of the 
infection process. 
PHL as a multivalent lectin displays an avidity effect, which 
significantly increases affinity towards its ligands. For that 
reason, compounds containing multiple carbohydrate moieties 
could be the most potent inhibitors. A new set of tri- and 
tetravalent glycoclusters with different architectures and 
valences were designed to provide an opportunity to evaluate 
the impact of topology and valency on binding properties toward 
PHL. Here, we present the preparation of di-, tri- and tetravalent 
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fucoclusters and study their interaction with the recombinant 
PHL lectin from P. asymbiotica. 
Results and Discussion 
Synthesis 
Similarly to our recent works[6,7], propargylated methyl gallate 1[8] 
and pentaerythritol 2[9] were chosen as multivalent scaffolds, and 
heterobifunctionalized tetraethylene glycol 3[10] and ethylene 
glycol 4[11] were used as linkers with different lengths. Based on 
the known X-ray structure of PHL, the average distances 
between the fucose-binding sites is approximately 19 Å, so 
these linkers are long enough that the a-L-fucose-units of the 
fucoclusters are able to bind to more than one binding pocket of 
the lectin. 
We efficiently prepared propargyl a-L-fucoside 5 by Fischer 
glycosylation using sulfamic acid[12] and utilized it in both 
unprotected and acetylated form 6[13] to create multivalent 
structures (Figure 1). 
Figure 1. Building blocks for the fucoclusters. 
The fucoclusters were built from the above structural elements 
from the inside out starting from the central cores applying two 
consecutive 1,3-dipolar azide-alkyne cycloaddition click 
reactions. First, the tri- and tetravalent cores 1 and 2 were 
coupled with bridges 3 and 4, respectively, via the copper(I)-
catalyzed azide-alkyne cycloaddition click reaction (CuAAC) to 
obtain tosylated compounds 7, 9, 11 and 13, in good yields. The 
tosyl groups of all scaffolds were converted into azido functional 
groups using sodium azide to result in compounds 8, 10, 12 and 
14, which were also suitable for further click reactions (Scheme 
1).  
Scaffolds containing tetraethylene glycol bridges 8 and 12 were 
coupled by CuAAC reaction with propargyl 2,3,4-tri-O-acetyl-a-L-
fucopyranoside 6 to produce the protected fucoclusters 15 and 
17, respectively, while click reaction between the same scaffolds 
and propargyl a-L-fucopyranoside 5 provided the final products 
16 and 18 directly (Scheme 2). The latter two compounds were 
also obtained by the Zemplén deacetylation of 15 and 17, 
respectively. Comparing the above syntheses with the 
unprotected and protected sugars 5 and 6, using the free sugar 
was not only a shorter, but also a more efficient procedure, 
although the isolation and purification were more demanding. 
(While the overall yields of compounds 16 and 18 were 60% and 
65% respectively using free fucoside, these yields decreased to 
38% and 32% when using the protected fucoside.) For this 
reason, we chose the shorter reaction pathway for further 
synthesis. 
Based on the same strategy, scaffolds 10 and 14 equipped with 
an ethylene glycol bridge were reacted with propargyl a-L-
fucopyranoside 5 by copper(I)-catalyzed cycloaddition to result 
in the final products 19 and 20 (Scheme 3). 
Our further aim was the examination of the role and effect of the 
linker and the triazole-ring in the lectin-carbohydrate interactions. 
For this reason, compounds 5, 22 and 23 were also provided for 
biological investigations. Compound 5 (propargyl alpha-L-
fucoside) is suitable for investigations to define the role of the 
monomer L-fucose. Moreover, compound 5 was reacted with 
azido-tetraethylene glycol derivative 4 under the condition of 
click reaction, then tosyl group was subsequently replaced with 
azide, to yield compound 22 (49% for two steps), which 
can provide information about the potency of the ethylene 
glycol linker-armed monomer. Finally, compound 5 was coupled 
with diazido-tetraethylene glycol 21[14] via click reaction, to 
yield compounds 23 (35%) and 24 (12%), which can serve 
information about the binding properties of the tetraethylene 
glycol linker-armed monomer and dimer (Scheme 4). 
 
Scheme 1. Synthesis of multivalent scaffolds having functionalized ethylene 
glycol (10 and 14) and tetraethylene glycol (8 and 12) linker arms. 
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The interaction of mono- and multivalent fucosylated ligands 
with PHL was investigated by a few methods. At first 
hemagglutination inhibition assay was utilized as a simple 
microscopy method to preselect the most efficacious inhibitors. 
Subsequently two biophysical techniques - isothermal titration 
calorimetry (ITC) and surface plasmon resonance (SPR) - were 
employed. The presence of fucose-binding lectins on the surface 
of P. asymbiotica subsp. australis was indirectly tested through 
the cross-linking of bacterial cells caused by multivalent ligands. 
In summary, these methods provide information about the 
binding affinity, inhibition potency and effect of the compounds 
on cell cross-linking. For a better structural characterization of 
the interaction of PHL with ligands, ligand-soaking of PHL 
crystals and STD-NMR experiments were carried out. 
Scheme 2. Synthesis of tri- and tetravalent fucodendrons 16 and 18 
containing TEG-linkers.  
Scheme 3. Synthesis of tri- and tetravalent a-L-fucoside-containing dendrons 
19 and 20 having short linker arms. 
 
Scheme 4. Synthesis of the linker-armed monomers 22 and 23. 
Hemagglutination inhibition assay 
PHL, being a fucose-specific lectin, was shown to agglutinate 
papain-treated RBCs of blood group O[5] with surface-exposed 
terminal trisaccharide a-L-Fucp-(1®2)-b-D-Galp-(1®3/4)-D-
GlcpNAc. This property was also used to assess the inhibition 
potency of the set of a-L-fucoside molecules on 
hemagglutination by PHL (Figure 2). All of them were able to 
inhibit the hemagglutination with at least four times higher 
potency than L-fucose (Table 1). Tetravalent compound 18 was 
shown to be the most efficient inhibitor followed by compounds 
16, 19 and 20, all of them being half as efficient as 18. 
Compound 20 is also a tetravalent fucocluster, but contains 
shorter linkers, which may be not able to connect binding sites, 
in contrast to compound 18. 
Figure 2. Representatives of mono-, di-, tri-, and tetrafucosylated compounds 
and their influence on hemagglutination of RBC O caused by PHL. Two-fold 
serially diluted carbohydrate compounds 5, 24, 16 and 18 were able to inhibit 
hemagglutination at minimal concentrations 200 µM, 100 µM, 50 µM and 
25 µM, respectively. Hemagglutination of RBC O caused by PHL without 
inhibitor is shown on the picture in the left down corner. 
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Table 1. Hemagglutination inhibition assay with PHL. Minimal inhibitory 
concentrations (MIC) of synthetized inhibitors and their potency towards L-
fucose was determined. To assess the contribution of valency to the MIC, an 
affinity improvement factor β was calculated as the relationship MICL-
fucose/(valency × MICligand). 
Ligand Valency MIC [µM] Potency b 
L-Fuc 1 3,200 1 1 
Compound 23 1 800 4 4 
Me-a-L-Fuc 1 400 8 8 
Compound 5 1 200 16 16 
Compound 22  1 200 16 16 
Compound 24  2 100 32 16 
Compound 19  3 50 64 21 
Compound 16 3 50 64 21 
Compound 20  4 50 64 16 
Compound 18  4 25 128 32 
 
Surface plasmon resonance 
The surface plasmon resonance (SPR) technique was employed 
to analyse the competitive inhibition of PHL binding to a 
multivalent chip surface. The experiments were performed using 
a constant concentration of PHL and increasing concentration of 
the studied compounds to enable the determination of IC50. 
Tetravalent compounds 18 and 20 appeared to be the most 
efficient inhibitors, with IC50 reaching 200 nM and 96 nM, 
respectively (Table 2). The trivalent compounds 16 and 19 had a 
weaker inhibitory potential, but were still in the nanomolar range, 
which is three orders of magnitude lower than for free L-fucose. 
The monovalent ligands proved to be at least three times more 
efficient than L-fucose. Logarithmic plots of IC50 and the 
inhibition curves from SPR measurements displayed in Figure 3 
nicely demonstrate the growing inhibitory effect through 
monovalent, divalent and tri-/tetravalent a-L-fucoside 
compounds. 
 
Table 2. Inhibitory effect of representative carbohydrates on PHL binding to 
immobilized L-fucoside. IC50 was determined from a plot of serial dilutions vs. 
% inhibition, and potency was relative to L-Fuc. To assess the contribution of 
valency to the IC50, an affinity improvement factor β was calculated as the 
relationship IC50,L-fucose/(valency × IC50,ligand). 
Ligand Valency IC50 [µM] Potency b 
L-Fuc 1 361 1 1 
Compound 23 1 108 3 3 
Me-a-L-Fuc 1 68 5 5 
Compound 5 1 54 7 7 
Compound 22  1 52 7 7 
Compound 24  2 3.2 118 59 
Compound 19  3 0.37 979 326 
Compound 16 3 0.35 1030 343 
Compound 20  4 0.20 1806 452 
Compound 18  4 0.10 3784 946 
 
Figure 3. IC50 determination of fucoclusters towards PHL from SPR 
measurements. (A) A logarithmic plot of inhibition curves determined from 
SPR experiments. Individual types of line correspond to monovalent (dotted), 
divalent (dashed), trivalent (dashdotted) and tetravalent (densely dashed) 
ligands. (B) A logarithmic plot of IC50 for individual mono-/multivalent a-L-
fucoside compounds. Standard deviations were calculated from three 
independent measurements. Individual type of pattern corresponds to 
monovalent (dotted), divalent (dashed), trivalent (dashdotted) and tetravalent 
(densely dashed) ligands. 
Isothermal titration calorimetry 
The binding of PHL to multivalent a-L-fucoside compounds was 
further characterized by isothermal titration calorimetry (ITC) to 
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determine the complete thermodynamic profile of the molecular 
interactions. As for monovalent fucoclusters, all of them were 
proved to be low-affinity ligands for PHL. The data for compound 
23 were impossible to evaluate. The other two monovalent 
ligands provided better results. In both cases, the ITC curves 
indicated a low affinity toward PHL, as usually observed for 
lectin/saccharide interactions (Figure 4). The stoichiometry value 
n was assessed to be around 4 and the dissociation constants 
were in the submilimolar range (Table 3). As expected, the 
enthalpy of binding for shorter compounds was less negative 
than for longer chains. Shorter and more rigid compounds 5 and 
22 also exhibited a positive entropy contribution, in contrast to 
other studied molecules. 
The ITC data for multivalent fucosylated compounds provided a 
more interesting set of results (Table 3 and Figure 4). The 
values indicate a strong interaction between PHL and 
multivalent fucoclusters, with an affinity in the low micromolar 
range. The stoichiometry varies between 2 and 3 ligand 
molecules per PHL monomer. Generally, tetravalent ligands 
exhibited a higher affinity than tri- or divalent ones, however, an 
interesting effect of linker length was observed. Short linkers 
seem to disfavour ligand binding. Thus, compounds with shorter 
linkages (tetravalent 20 and trivalent 19) bind with considerably 
lower affinity than longer linker-containing tetravalent 18 and 
trivalent 16, respectively. Unusually high enthalpy and entropy 
contributions were observed for compound 19. This suggests 
the possibility of a different binding mode being employed. 
The highest affinity was observed towards tetravalent compound 
18, with a KD twice as good as the second best tetravalent 
compound 20, and more than a thousand times better than free 
L-Fuc. It is interesting that trivalent compound 16 containing 
longer linkers has a comparable KD to tetrafucosylated 
compound 20 with a shorter spacer – the spacer length plays an 
important role in affinity. Likewise, dimeric fucocluster 24 is a 
little bit better than trivalent compound 19 with short linkers 
(Figure 4B).  
During the ITC measurements, we also observed an additional 
effect – the cross-linking of PHL caused by multivalent 
fucoclusters that was accompanied by the formation of visible 
precipitates. 
Table 3. Thermodynamic profiles for interaction between PHL and carbohydrate ligands determined by isothermal titration calorimetry using one site model fitting 
procedure at 25 °C (standard deviations were calculated from two independent measurements). To assess the contribution of valency to the affinity increase, an 
affinity improvement factor β was calculated as the relationship KD,L-fucose/(valency × KD,ligand). 
Ligand Valency n KD [µM] DH [kJ mol-1] -TDS [kJ mol-1] DG [kJ mol-1] b 
 
Compound 23 1 ND[a] ND[a] ND[a] ND[a] ND[a] ND[a] 
L-Fuc 1 3[b] 1,395 ± 34 -59.5 ± 1.0 43.2 -16.3 ± 0.3 1 
Me-a-L-Fuc 1 2.9 ± 0.2 267 ± 11 -59.0 ± 4.2 38.6 -20.4 ± 1.5 5 
Compound 22  1 4.0 ± 0.3 175 ± 18 -14.6 ± 1.4 -6.9 -21.5 ± 2.1 8 
Compound 5  1 4.6 ± 0.3 149 ± 16 -8.8 ± 0.7 -13.1 -21.9 ± 1.8 9 
Compound 19  3 2.3 ± 0.0 8.5 ± 0.5 -65.4 ± 0.7 36.5 -28.9 ± 0.3 55 
Compound 24  2 2.5 ± 0.0 6.6 ± 0.7 -42.2 ± 0.8 12.5 -29.7 ± 0.6 106 
Compound 16 3 2.9 ± 0.1 3.6 ± 0.8 -54.4 ± 1.4 23.4 -31.0 ± 0.8 129 
Compound 20 4 2.1 ± 0.1 3.1 ± 1.0 -56.9 ± 2.3 25.5 -31.4 ± 1.2 113 
Compound 18 4 1.9 ± 0.0 1.2 ± 0.4 -77.5 ± 2.6 43.6 -33.9 ± 1.1 290 
[a] Values not determined because of low affinity interaction. One-site model for compound 23 was unable to reach a meaningful fit. [b] The stoichiometry value of 
L-fucose was fixed during fitting procedure because of low-affinity interaction. The value was	 derived from the X-ray crystal structure of the PHL/Me-a-L-Fuc 
complex. 
 
 
  
10.1002/chem.201705853
Ac
ce
pt
ed
 M
an
us
cr
ip
t
Chemistry - A European Journal
This article is protected by copyright. All rights reserved.
FULL PAPER    
 
 
 
 
 
Figure 4. (A) Thermodynamic profiles for interaction between PHL and 
mono/multivalent a-L-fucoside compounds determined by isothermal titration 
calorimetry at 25 °C (standard deviations were calculated from two 
independent measurements). (B) Selected ITC curves of PHL (50 µM) titration 
by compound 5 (5 mM), 24 (5 mM) and 19 (1.5 mM). 20 injections of 2.0 µl of 
fucoclusters were added every 240 s to a PHL-containing cell. Lower plots 
show the total heat released as a function of total ligand concentration for the 
titration shown in the upper panels. 
Aggregation of PHL lectin monitored by 1H NMR 
spectroscopy 
The aggregation behaviour of the PHL lectin upon titration with 
the five a-L-fucoside-containing derivatives (monomer 5, trivalent 
16 and 19 and tetravalent 18 and 20) has been subsequently 
investigated and compared by 1H NMR spectroscopy, monitoring 
the change (decrease) in protein signal intensity as a function of 
the actual ligand concentration (Figure 5). For a fair comparison 
of the extent of PHL aggregation, each tested fucoside ligand 
was added to a similar (ca. 40-50 μM) solution of PHL in 
concentrations ranging from 6 to 25 μM. Before each titration 
assay, a regular 1H NMR spectrum was recorded on the sample 
containing PHL alone, providing the reference protein signal 
intensity for quantification of protein aggregation during the 
subsequent titration steps. As expected, the monovalent ligand 5 
did not lead to any noticeable aggregation of PHL, even when its 
concentration was increased up to 0.1 mM. In contrast, when 
titrating the multivalent ligands into the sample containing PHL a 
significant reduction (drop) in the protein signal envelope was 
observed, suggesting the formation of large, non-soluble 
aggregates via possible cross-linking between the multivalent 
ligands and PHL. The level of aggregation, however, varied 
according to the type and concentration of the multivalent ligand 
tested. The tri- and tetravalent fucodendron derivatives 
containing TEG-linkers (16 and 18, respectively) led to the 
formation of smaller amount of non-soluble aggregates than the 
ones (19, 20) with the shorter linker arm. Specifically, at 6.2 μM 
of fucodendrons with a TEG-linker, about 30 % of total protein 
aggregated (precipitated), while upon adding the ligands with a 
shorter linker at the same concentration, only ca. 50 % of the 
protein remained in solution. 
 
X-ray structure of PHL/compound 5 complex 
The PHL lectin was shown to form a dimeric structure consisting 
of two seven-bladed β-propellers with two types of binding sites 
situated between the blades.[5] Both types of binding sites have 
different amino acid composition and binding preferences. Also, 
the non-identity of individual potential binding sites within the 
same type was proposed. The direct study of complexes with 
branched fucosylated structures was not possible, as mixing 
PHL with the multivalent compound leads to protein precipitation, 
preventing the co-crystallization. Soaking ligand-free PHL 
crystals with a low concentration of individual branched 
compounds did not result in complex formation, while soaking 
with their higher concentrations led to a crystal decomposition. 
Therefore, to determine the potential PHL binding sites for 
studied molecules, we soaked the crystals with monomeric 
compound 5. 
The structure of the PHL/compound 5 complex was determined 
using X-ray diffraction (Table 4). The lectin in the complex 
retains the seven-bladed β-propeller fold (Figure 6A, B) identical 
to the ligand-free form.[6] The differential electron density map 
was clear enough to identify compound 5 monomers in five of 
the seven potential fucose binding sites of monomer A – site 1F, 
3F, 5F, 6F and 7F (Figure 6C). In monomer B, the ligand binding 
in site 5F was affected by intermonomeric contacts in the crystal, 
and it was not possible to determine the precise position of the 
ligand. Compound 5 is bound via its fucosylated part, which 
adopts the same orientation as Me-a-L-Fuc in the previously 
determined PHL/Me-a-L-Fuc complex.[5] Thus, the O3, O4 and 
O5 of the fucosyl part is coordinated to the protein backbone of 
the Gly/Gln and Val residues on one side of the pocket and 
backbone and side chain of the Thr residue on the other side of 
the pocket. The C6 methyl group and hydrophobic surface of 
Fuc C3, C4 and C5 are stabilized through CH-π interactions with 
two Trp residues, and O3 may be further stabilized by a water 
bridge to the neighbouring Asp residue (Figure 6C – sites 3F, 5F, 
7F). Compared to the PHL/Me-a-L-Fuc complex, more binding 
sites were occupied by compound 5, which agrees with the 
higher affinity towards compound 5 than towards Me-a-L-Fuc, as 
was determined by ITC and hemagglutination inhibition 
experiments. 
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Figure 5. 1H NMR experiments (500 MHz, T = 298 K) for monitoring the aggregation of the PHL lectin in the presence of increasing concentration of the ligands (5, 
16, 18, 19 and 20). 40-50 μM solution of PHL in D2O (PBS) was titrated by increasing amount of ligands. The relevant ligand concentrations together with the 
percentage of PHL remaining in solution (referenced to pure PHL solution) are given above the spectra. All NMR spectra were recorded with 512 number of scans, 
allowing 1 s for relaxation between subsequent transients. 
 
Table 4. Data-collection and refinement statistics for PHL/compound 5 
complex. Values in parentheses correspond to the highest resolution shell. 
PDB ID 6F5W 
Beamline BESSY, 14.1 
Wavelength (Ǻ) 0.9184 
Space group P3221 
Unit-cell parameters  
     a and b (Å) 80.57 
     c (Å) 224.80 
Resolution range (Ǻ) 44.96-1.91 (1.96-1.91) 
Reflections measured 733262 (97948) 
Unique reflections 66991 (9584) 
Completeness (%) 99.8 (98.26) 
CC1/2 99.6 (66.2) 
Rmerge 0.206 (1.319) 
Multiplicity 10.9 (10.2) 
<I/σ (I) > 9.4 (1.8) 
Reflections used 63648 
Reflections used for Rfree 3273 
R factor (%) 17.28 
Rfree (%) 21.28 
R.m.s.d. bond lengths (Ǻ) 0.011 
R.m.s.d. bond angles (°) 1.43 
No. of water molecules 465 
No. of non-H atoms (total) 5991 
Ramachandran plot  
     Residues in most favorable regions (%) 96.9 
     Residues in allowed regions (%) 3.1 
 
Unexpectedly, the clear electron density for compound 5 was 
also identified in the galactose-binding site 4G (Figure 6D). The 
ligand is coordinated by the same residues as in the case of 
D-Gal, however the orientation is different, with the aliphatic 
chain on O1 pointing outwards. The ligand is bound via a 
hydrogen bond network to the side chains of Arg186 (O1 and 
O2), Glu188 and Gln251 (O2 and O3), Trp259 (O3 and O4) and 
backbone of Gly257 (O4). The ligand is further stabilized by a 
water bridge between Glu215 and O4, a CH-π interaction with 
Trp202 and cation-π interaction between the guanidium group of 
Arg186 and propargyl group of the ligand. Based on this 
observation, we can propose the possible design of a single 
inhibitor that would target both types of PHL binding sites at the 
same time.  
 
Binding of fucoside-containing ligands to PHL lectin 
characterized by 1H STD and competition STD NMR 
experiments 
STD NMR experiments[15–17] were performed to support and 
further characterize the binding of a-L-fucoside-containing 
ligands to PHL. The corresponding spectra are in Figure 7. For 
the monovalent ligand 5, clear STD effects were observed for all 
sugar ring protons. The percentage STD intensities were similar 
for protons H1-H4 (~100 %), while H5 and the CH3 protons 
exhibited slightly smaller STD effects (55 % and 82 %, 
respectively). These facts indicate the direct involvement of the 
sugar ring in the binding to the lectin. A significant STD 
response (74 %) was also observed	 for the CH2 protons of the 
propargyl group, suggesting that the binding event may involve 
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this group as well. It should be noted, however, that the intensity 
of the propargyl CH-proton is significantly reduced due to partial 
deuteration in D2O, therefore its STD response is likely also 
attenuated and so that not quantified in %. It should be also 
mentioned that the irradiation of the protein in the aromatic 
signal region led to a significantly lower saturation of all ligand 
protons with correspondingly smaller STD effects. This fact may 
suggest that the binding pocket of the PHL lectin probably 
involves more aliphatic than aromatic amino acid residues 
responsible for sugar binding.  
To monitor the binding of the high-affinity multivalent ligands and 
to identify their probable binding sites, competition STD 
experiments were also carried out. The corresponding STD 
spectra are shown in Figure 7B. As can be seen, all STD signals 
decreased considerably upon adding the multivalent ligands 
(first trivalent, 16, lastly tetravalent, 18) to the sample initially 
containing the monovalent ligand alone. These data may confirm 
that both multivalent ligands compete with the monovalent ligand 
for the same or at least partially the same (overlapping) binding 
site of the PHL lectin. 
 
 
 
 
Figure 6. Structure of PHL complex with compound 5. (A) PHL monomer (chain A) overall architecture with compound 5 shown as magenta sticks. Individual 
binding sites are labelled in black (front plane) or grey (back plane) (B) Side view of PHL dimer with chain B shown in grey and without ligands. (C) Individual PHL 
fucose-type binding sites with compound 5 (magenta) bound. Amino acids responsible in ligand binding are highlighted and labelled. (D) PHL galactose-type 
binding site with compound 5 (magenta) bound and PHL galactose-type binding site with D-Gal (yellow) bound (PDB ID: 5MXH). Colour code for panels C/D: 
amino acids involved in ligand-binding through H-bond – cyan, CH-π interaction – orange or water bridge – grey.  
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Figure 7. (A) STD experiments for the monovalent fucoside ligand 5 complexed with the PHL lectin. The estimated molar ratio of sugar/lectin is ca. 100/1. i.-ii.) 
The corresponding STD spectra (up-scaled by a factor of 64) depicted after saturating for 3 s at δ -1.5 and 10.5 ppm, respectively. The percentage STD 
intensities are referenced to the STD response of H-1 proton (100 %) obtained upon irradiation at the aliphatic signal region of PHL at -1.5 ppm. On- and off-
resonance data were acquired alternately up to total of 1424 scans recorded for each FID; iii.) The regular 500 MHz 1D 1H NMR spectrum with the assignment of 
resonances. (B) Competition STD experiments for characterizing the binding of the high affinity ligands (16 and 18) to PHL. The bottom spectrum corresponds to 
the regular 1H NMR spectrum of ligand 5. The other spectra are the corresponding STD responses recorded on samples containing the ligand 5 at constant 2 mM 
concentration, while the multivalent ligands were subsequently added in increasing concentrations. The top (reference) STD spectrum corresponds to the sample 
containing only the monovalent ligand. The other spectra were recorded on samples containing trivalent ligand 16 at 70 μM; at 100 μM; and lastly, the mixture of 
trivalent 16 at 100 μM and tetravalent 18 at 60 μM. For better visualization of the STD signal drop due to competition, an overlay of the STD responses of H1 is 
shown in the	inset at larger scale. Note that during titration no aggregation of protein was observed. 
P. asymbiotica cross-linking - Bacterial aggregation 
properties 
 The aggregation of PHL by multivalent fucoclusters was 
observed in many experiments and therefore we decided to test 
it at a higher level. We performed a series of in vitro aggregation 
assays to reveal the aggregation properties of fucosylated 
compounds towards P. asymbiotica subsp. australis. Prior to 
each assay, we confirmed the absence of aggregates in the 
negative control – bacterial cells in 50% DMSO (Figure 8A). We 
studied mono-, di-, tri- and tetravalent fucoclusters as ligands 
(Table 5, Figure 8). The monovalent compound 5 did not create 
any aggregates, as expected. With all multivalent compounds, 
we observed bacterial aggregates of spherical shape and 
variable size that confirmed that all multivalent compounds are 
capable of interacting with a cell surface’s receptors. The 
concentration of the first appearance of aggregates varied 
according to the nature of the ligand used (Figure 8C). The 
highest efficiency (0.63 mM) was observed for the trifucosylated 
compound 16. Against our expectations, it was higher than for 
tetrameric fucoclusters (compounds 18 and 20) that aggregated 
cells at a concentration of 5 mM. A similar result was obtained 
for the other trivalent compound 19. This could be caused by the 
structure of compound 16, its longer linker arms allow a higher 
flexibility of the compound and easier reach on different cells. 
 
 
 
 
 
 
 
Table 5. The determination of the minimal concentration of multivalent 
fucoclusters able to aggregate P. asymbiotica cells. 
Ligand The	 lowest	 concentration	 able	 to	 aggregate	 P.	
asymbiotica	cells 
Compound 5 No visible aggregation in used concentration 
Compound 24  5 mM 
Compound 19  2.5 mM 
Compound 20  2.5 mM 
Compound 18  2.5 mM 
Compound 16  0.63 mM 
 
 
  
10.1002/chem.201705853
Ac
ce
pt
ed
 M
an
us
cr
ip
t
Chemistry - A European Journal
This article is protected by copyright. All rights reserved.
FULL PAPER    
 
 
 
 
 
Figure 8. Representative images of optical microscopy observation (200x) of 
bacterial cell aggregation for Photorhabdus asymbiotica subsp. australis with 
different fucosylated clusters. Mixture with 50% DMSO was used as negative 
control (A). Concentrations of the first appearance of aggregates are 
presented (C) as well as one dilution step lower (B) and higher (D). No 
aggregates were observed for a monovalent fucocluster (compound 5). 
Background of all pictures was subtracted in GIMP software. 
Conclusions 
P. asymbiotica has proved to be not only an entomopathogenic 
bacteria, but also a dangerous human pathogen that causes a 
difficult-to-treat disease. Suitable inhibitors preventing the host-
pathogen interaction should be helpful in the early steps of P. 
asymbiotica infection. For this purpose, monovalent fucosides 
and di-, tri-, and tetravalent glycoclusters functionalized with a-L-
fucosides were designed and prepared using click chemistry. 
Their binding properties toward the PHL lectin from P. 
asymbiotica have been evaluated by hemagglutination, ITC, 
SPR, NMR, X-ray crystallography, and cell cross-linking. 
We have demonstrated that all of the compounds were able to 
inhibit the PHL binding activity and the affinity for multivalent 
ligands reached nanomolar values, and there is an obvious 
relation between the increasing number of fucoses per cluster 
and increasing affinity. The potency of ligands depended on the 
valency, architecture and flexibility of the fucocluster, but all 
ligands proved to be up to several orders of magnitude better 
ligands than L-fucose. Moreover, only multivalent ligands were 
able to cross-link PHL, resulting in the formation of visible 
precipitation. We used this property and investigated the 
agglutination of P. asymbiotica bacteria via the surface lectins 
that are likely present, as was proved for other cells (e.g. P. 
aeruginosa, E. coli, T cell leukemia line).[18–20] We observed nice 
cell clumps at different concentrations of multivalent compounds, 
showing the specificity of the interaction and proving the 
presence of lectins on the bacterial surface. In conclusion, we 
provide complete assays of the action of mono- and multivalent 
fucoclusters on the P. asymbiotica lectin PHL and useful 
information for their possible employment in medical treatments. 
Experimental Section 
Synthesis - General methods 
Optical rotations were measured at room temperature with a Perkin-
Elmer 241 automatic polarimeter. TLC analysis was performed on 
Kieselgel 60 F254 (Merck, Germany) silica gel plates with visualization by 
immersing in a sulfuric-acid solution (5% in EtOH) followed by heating. 
Column chromatography was performed on silica gel 60 (0.063–0.200 
mm, Merck, Germany), flash column chromatography was performed on 
silica gel 60 (Merck 0.040–0.063 mm). Gel filtration was performed on 
Sephadex G-25 (Sigma-Aldrich, USA), using methanol as the eluent. 
Organic solutions were dried over MgSO4 and concentrated under 
vacuum. The 1H (400 MHz) and 13C NMR (100.28 MHz) spectra were 
recorded with Bruker Avance II 400 spectrometer (Bruker, Germany). 
Chemical shifts are referenced to Me4Si or DSS (0.00 ppm for 1H) and to 
solvent signals (CDCl3: 77.00 ppm, CD3OD: 49.15 ppm, DMSO-d6: 39.51 
ppm for 13C). MS (MALDI-TOF) analysis was carried out in positive 
reflection mode with a BIFLEX III mass spectrometer (Bruker, Germany) 
with delayed-ion extraction. The matrix solution was a saturated solution 
of 2,5-dihidroxy-benzoic acid (DHB) in DMF. Elemental analysis was 
performed on an Elementar Vario MicroCube instrument (Elementar UK 
Ltd., UK). 
General method A for azide-alkyne click reaction. Et3N (1 equiv./alkyne) 
and copper(I)-iodide (0.1 equiv./alkyne) were added to a stirred solution 
of alkyne (0.2 mmol) and azide (1.3 equiv./alkyne) in CH3CN (3 mL) 
under an argon atmosphere and stirred overnight at room temperature. 
The reaction mixture was evaporated, and the crude product was purified 
by flash column chromatography to give the desired compound. 
General method B for nucleophilic substitution of tosylates to azide. NaN3 
(2 equiv.) was added to a stirred solution of tosylate (1 mmol) in DMF (5 
mL) under an argon atmosphere and stirred overnight at room 
temperature. The reaction mixture was diluted with water dropwise, 
stirred for further 5 minutes and evaporated. The residue was dissolved 
in CH2Cl2 (200 mL) and extracted with water (2 x 50 mL) and brine (50 
mL), dried over MgSO4, filtered and evaporated. The crude product was 
purified by flash column chromatography to give the desired compound. 
General method C for Zemplén-deacetylation. The catalytic amount of 
NaOMe (pH ~ 9) was added to a stirred solution of ester (0.2 mmol) in 
dry MeOH (5 mL) and stirred overnight at room temperature. The 
reaction mixture was neutralized with Amberlite IR-120 H+ ion-exchange 
resin, filtered and evaporated, and then the crude product was purified by 
flash column chromatography and gel filtration to give the desired 
compound. 
Compound 8. Azide compound 3 (637 mg, 1.71 mmol) and alkyne 1 
(131 mg, 0.44 mmol) were reacted in CH3CN according to general 
method A. The crude product was purified by flash column 
chromatography (CH2Cl2/MeOH 98:2) to give compound 7 (540 mg, 
87%) as a colourless syrup. Rf = 0.50 (CH2Cl2/MeOH 97:3). The product 
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7 (540 mg, 0.38 mmol) was converted into azide according to general 
method B. The crude product was purified by flash column 
chromatography (CH2Cl2/MeOH 95:5) to give compound 8 (254 mg, 
65%) as a colourless syrup. Rf = 0.39 (CH2Cl2/MeOH 95:5); 1H NMR 
(400 MHz, CDCl3): δ = 7.96, 7.89 (2 x s, 3H, 3 x CH triazole), 7.44 (s, 2H, 
arom), 5.24 (d, J = 1.8 Hz, 6H, 3 x CH2 propargyl), 4.58 (t, J = 5.1 Hz, 4H, 
2 x NCH2 TEG), 4.51 (t, J = 5.3 Hz, 2H, NCH2 TEG), 3.92-3.85 (m, 10H, 
5 x OCH2 TEG), 3.65-3.58 (m, 29H, 13 x OCH2 TEG, COOCH3), 3.37-
3.35 (m, 6H, 3 x CH2 TEG) ppm; 13C NMR (100 MHz, CDCl3): δ = 166.3 
(1C, COOCH3), 152.0 (2C, Cq arom.), 144.0, 143.1 (3C, 3 x Cq triazole), 
141.6 (1C, Cq arom.), 125.5 (1C, Cq arom.), 124.8, 124.4 (3C, 3 x CH 
triazole), 109.1 (2C, arom.), 70.6, 70.5, 69.9, 69.3, 69.2 (18C, 18 x CH2 
TEG), 66.4, 63.1 (3C, 3 x CH2 propargyl), 52.3 (1C, COOCH3), 50.6, 50.2, 
50.0 (6C, 6 x NCH2 TEG) ppm. MS (MALDI-TOF): m/z calcd for 
C41H62N18NaO14: 1054.05 [M+Na]+; found: 1053.79; elemental analysis 
calcd (%) for C41H62N18O14: C 47.76, H 6.06; found: C 47.81, H 6.12. 
Compound 10. Azide compound 4 (626 mg, 2.59 mmol) and alkyne 1 
(199 mg, 0.67 mmol) were reacted in CH3CN according to general 
method A. The crude product was purified by flash column 
chromatography (CH2Cl2/MeOH 97:3) to give compound 9 (700 mg, 
88%) as a colourless syrup. Rf = 0.18 (CH2Cl2/MeOH 97:3). Compound 9 
(474 mg, 0.5 mmol) was converted into azide according to general 
method B. The crude product was purified by flash column 
chromatography (CH2Cl2/MeOH 97:3) to give compound 10 (175 mg, 
58%) as a colourless syrup. [α]24D +1.3 (c = 0.15, CHCl3); Rf = 0.48 
(CH2Cl2/MeOH 95:5); 1H NMR (400 MHz, CDCl3): δ = 7.97 (s, 3H, 3 x CH 
triazole), 7.41 (s, 2H, arom.), 5.31 (d, J = 1.3 Hz, 2H, CH2 propargyl), 
5.25 (s, 4H, 2 x CH2 propargyl), 4.55-4.51 (m, 6H, 3 x NCH2 ethylene 
glycol), 3.88-3.80 (m, 9H, 3 x CH2 ethylene glycol, COOCH3) ppm; 13C 
NMR (100 MHz, CDCl3): δ = 166.0 (1C, COOCH3), 151.6 (1C, Cq arom.), 
144.2, 143.4 (3C, 3 x Cq triazole), 141.1 (1C, Cq arom.), 125.5 (1C, Cq 
arom.), 124.6, 124.1 (3C, 3 x CH triazole), 108.8 (2C, arom.), 66.0, 62.7 
(3C, 3 x CH2 propargyl), 52.1 (1C, COOCH3), 50.3, 49.2, 49.0 (6C, 6 x 
NCH2 ethylene glycol) ppm. MS (MALDI-TOF): m/z calcd for 
C23H26N18NaO5: 657.22 [M+Na]+; found: 657.14; elemental analysis calcd 
(%) for C23H26N18O5: C 43.53, H 4.13; found: C 43.59, H 4.21. 
Compound 12. Azide compound 3 (850 mg, 2.27 mmol) and alkyne 2 
(126mg, 0.44 mmol) were reacted in CH3CN according to general 
method A. The crude product was purified by flash column 
chromatography (CH2Cl2/MeOH 97:3) to give compound 11 (474 mg, 
61%) as a colourless syrup. Rf = 0.29 (CH2Cl2/MeOH 97:3). Compound 
11 (474 mg, 0.27 mmol) was converted into azide according to general 
method B. The crude product was purified by flash column 
chromatography (CH2Cl2/MeOH 95:5) to give compound 12 (337 mg, 
51%) as a colourless syrup. Rf = 0.12 (CH2Cl2/MeOH 95:5); 1H NMR 
(400 MHz, CDCl3): δ = 7.73 (s, 4H, 4 x CH triazole), 4.55-4.53 (m, 16H, 4 
x CH2 propargyl, 4 x NCH2 TEG), 3.89 (t, J = 5.2 Hz, 8H, 4 x OCH2 TEG), 
3.68-3.62 (m, 40H, 20 x OCH2 TEG), 3.48 (s, 8H, 4 x CH2 pentaerythrit), 
3.39-3.37 (m, 8H, 4 x CH2 TEG) ppm; 13C NMR (100 MHz, CDCl3): δ = 
145.1 (4C, 4 x Cq triazole), 123.7 (4C, 4 x CH triazole), 70.7, 70.6, 70.5, 
70.0, 69.5 (24C, 24 x OCH2 TEG), 69.2 (4C, 4 x CH2 pentaerythrit), 64.9 
(4C, 4 x CH2 propargyl), 50.6, 50.1 (8C, 8 x NCH2 TEG), 45.3 (1C, Cq 
pentaerythrit) ppm. MS (MALDI-TOF): m/z calcd for C49H84N24NaO16: 
1287.64 [M+Na]+; found: 1287.91; elemental analysis calcd (%) for 
C49H84N24O16: C 46.51, H 6.69; found: C 46.56, H 6.75. 
Compound 14. Azide compound 4 (834 mg, 3.46 mmol) and alkyne 2 
(192 mg, 0.67 mmol) were reacted in CH3CN according to general 
method A. The crude product was purified by flash column 
chromatography (CH2Cl2/MeOH 95:5) to give compound 13 (430 mg, 
42%) as a colourless syrup. Rf = 0.22 (CH2Cl2/MeOH 95:5). Compound 
13 (420 mg, 0.34 mmol) was converted into azide according to general 
method B. The crude product was purified by flash column 
chromatography (CH2Cl2/MeOH 95:5) to give compound 14 (238 mg, 
94%) as a colourless syrup. [α]24D +16.1 (c = 0.18, CHCl3); Rf = 0.24 
(CH2Cl2/MeOH 95:5); 1H NMR (400 MHz, CDCl3): δ = 7.77 (s, 4H, 4 x CH 
triazole), 4.59 (s, 8H, 4 x CH2 propargyl), 4.56-4.53 (m, 8H, 4 x NCH2 
TEG), 3.84-3.81 (m, 8H, 4 x CH2 TEG), 3.48 (s, 8H, 4 x CH2 
pentaerythrit) ppm; 13C NMR (100 MHz, CDCl3): δ = 145.4 (4C, 4 x Cq 
triazole), 123.4 (4C, 4 x CH triazole), 69.0 (4C, 4 x CH2 pentaerythrit), 
64.7 (4C, 4 x CH2 propargyl), 50.5, 49.2 (8C, 8 x NCH2 TEG), 45.1 (1C, 
Cq pentaerythrit) ppm. MS (MALDI-TOF): m/z calcd for C25H36N24NaO4: 
759.32 [M+Na]+; found: 759.53; elemental analysis calcd (%) for 
C25H36N24O4: C 40.76, H 4.93; found: C 40.82, H 5.03. 
Compound 15. Azide compound 8 (100 mg, 0.10 mmol) and alkyne 6 
(143 mg, 0.44 mmol) were reacted in CH3CN according to general 
method A. The crude product was purified by flash column 
chromatography (CH2Cl2/MeOH 95:5) to give compound 15 (96 mg, 
49%) as a colourless syrup. [α]24D –77.9 (c = 0.05, CHCl3); Rf = 0.28 
(CH2Cl2/MeOH 95:5); 1H NMR (400 MHz, CDCl3): δ = 7.95, 7.72, 7.71 (3 
x s, 6H, 6 x CH triazole), 7.44 (s, 2H, arom.), 5.36-5.26 (m, 12H, 3 x CH2 
propargyl, 3 x H-3, 3 x H-4), 5.18 (d, J = 3.6 Hz, 3H, 3 x H-1), 5.12 (dd, J 
= 10.8 Hz, J = 3.7 Hz, 3H, 3 x H-2), 4.82 (d, J = 12.4 Hz, 3H, 3 x CH2a 
propargyl), 4.66 (d, J = 12.4 Hz, 3H, 3 x CH2b propargyl), 4.53-4.51 (m, 
12H, 6 x NCH2 TEG), 4.21 (q, J = 6.4 Hz, 3H, 3 x H-5), 3.90-3.84 (m, 
15H, 6 x OCH2 TEG, COOCH3), 3.61-3.56 (m, 24H, 12 x OCH2 TEG), 
2.16, 2.02, 1.96 (3 x s, 27H, 9 x CH3 Ac), 1.13 (d, J = 6.5 Hz, 9H, 3 x 
CH3) ppm; 13C NMR (100 MHz, CDCl3): δ = 170.6, 170.4, 170.0 (9C, 9 x 
CO Ac), 166.3 (1C, COOCH3), 152.0 (2C, 2 x Cq arom.), 143.8, 142.9 
(6C, 6 x Cq triazole), 141.6 (1C, Cq arom.), 125.7 (1C, Cq arom.), 124.6, 
124.0 (6C, 6 x CH triazole), 109.2 (2C, arom.), 95.7 (3C, 3 x C-1), 71.2, 
68.0, 67.9, 64.7 (12C, skeleton carbons), 70.5, 70.4, 69.4, 69.3 (18C, 18 
x OCH2 TEG), 66.3, 62.8, 61.3 (6C, 6 x CH2 propargyl), 52.4 (1C, 
COOCH3), 50.4, 50.3 (6C, 6 x NCH2 TEG), 20.8, 20.7, 20.6 (9C, 9 x CH3 
Ac), 15.9 (3C, 3 x CH3); ppm. MS (MALDI-TOF) m/z calcd for 
C86H122N18NaO38: 2037.81 [M+Na]+ found: 2037.80; elemental analysis 
calcd (%) for C86H122N18O38: C 51.24, H 6.10; found: C 51.31, H 6.19. 
Compound 16. Method I.: Azide compound 8 (57 mg, 0.06 mmol) and 
alkyne 5 (50 mg, 0.25 mmol) were reacted in CH3CN according to 
general method A. The crude product was purified by flash column 
chromatography (CH3CN/H2O 7:3) to give compound 16 (54 mg, 60%) as 
a colourless syrup. Method II.: Compound 15 (74 mg, 0.04 mmol) was 
deacetylated according to general method C. The crude product was 
purified by flash column chromatography (CH2Cl2/MeOH 7:3) to give 
compound 16 (47 mg, 78%) as a colourless syrup. [α]24D +173.0 (c = 0.10, 
MeOH); Rf = 0.42 (CH2Cl2/MeOH 7:3);  1H NMR (400 MHz, D2O): δ = 
8.06, 7.94, 7.80 (3 x s, 6H, 6 x CH triazole), 7.38 (s, 2H, arom.), 5.14, 
5.08 (2 x s, 6H, 3 x CH2 propargyl), 4.89 (d, J = 2.9 Hz, 3H, 3 x H-1), 4.61 
(dd, J = 22.7 Hz, J = 13.3 Hz, 6H, 3 x CH2 propargyl), 4.57-4.44 (m, 12H, 
6 x NCH2 TEG), 3.85-3.75 (m, 18H, 3 x H-5, 6 x OCH2 TEG, COOCH3), 
3.71-3.70 (m, 6H, 3 x H-2, 3 x H-3), 3.66 (s, 3H, 3 x H-4), 3.46-3.42 (m, 
12H, 6 x OCH2 TEG), 3.41-3.39 (m, 12H, 6 x OCH2 TEG), 1.02 (d, J = 
6.5 Hz, 9H, 3 x CH3); 13C NMR (100 MHz, D2O): δ = 168.7 (1C, 
COOCH3), 152.5 (2C, 2 x Cq arom.), 145.0, 143.8 (6C, 6 x Cq triazole), 
141.3 (1C, Cq arom.), 126.7 (1C, Cq arom.), 126.6, 126.1 (6C, 6 x CH 
triazole), 110.2 (2C, arom.), 99.5 (3C, 3 x C-1), 72.8 (3C, 3 x C-4), 70.6 
(3C, 3 x C-2), 70.7, 70.5, 69.7, 69.6 (18C, 18 x OCH2 TEG), 69.0 (3C, 3 x 
C-3), 67.7 (3C, 3 x C-5), 66.0, 62.9, 61.5 (6C, 6 x CH2 propargyl), 53.8 
(1C, COOCH3), 51.1, 51.0, 50.9 (6C, 6 x NCH2 TEG), 16.2 (3C, 3 x CH3). 
MS (MALDI-TOF): m/z calcd for C68H104N18NaO29: 1659.71 [M+Na]+; 
found: 1659.80; elemental analysis calcd (%) for C68H104N18O29: C 49.87, 
H 6.40; found: C 49.92, H 6.50. 
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Compound 17. Azide compound 12 (85 mg, 0.05 mmol) and alkyne 6 
(94 mg, 0.28 mmol) were reacted in CH3CN according to general method 
A. The crude product was purified by flash column chromatography 
(CH2Cl2/MeOH 95:5) to give compound 17 (80 mg, 54%) as a colourless 
syrup. [α]24D –70.0 (c = 0.31, CHCl3); Rf = 0.22 (CH2Cl2/MeOH 95:5); 1H 
NMR (400 MHz, CDCl3): δ = 7.74, 7.73 (2 x s, 8H, 8 x CH triazole), 5.34 
(dd, J = 10.8 Hz, J = 3.3 Hz, 4H, 4 x H-3), 5.28 (d, J = 2.7 Hz, 4H, 4 x H-
4), 5.18 (d, J = 3.7 Hz, 4H, 4 x H-1), 5.12 (dd, J = 10.8 Hz, J = 3.7 Hz, 4H, 
4 x H-2), 4.82 (d, J = 12.4 Hz, 4H, 4 x CH2a propargyl), 4.66 (d, J = 12.4 
Hz, 4H, 4 x CH2b propargyl), 4.55-4.52 (m, 24H, 8 x NCH2 TEG, 4 x CH2 
propargyl), 4.22 (q, J = 6.4 Hz, 4H, 4 x H-5), 3.88 (t, J = 5.1 Hz, 16H, 8 x 
OCH2 TEG), 3.61-3.57 (m, 32H, 16 x OCH2TEG), 3.48 (s, 8H, 4 x CH2 
pentaerythrit), 2.16, 2.03, 2.01, 1.97 (4 x s, 36H, 12 x CH3 Ac), 1.13 (d, J 
= 6.5 Hz, 12H, 4 x CH3); 13C NMR (100 MHz, CDCl3): δ = 170.4, 170.2, 
169.8 (9C, 9 x CO Ac), 144.8, 143.6 (8C, 8 x Cq triazole), 123.8 (8C, 8 x 
CH triazole), 95.5 (4C, 4 x C-1), 71.0, 67.8, 67.7, 64.5 (16C, 4 x skeleton 
carbons), 70.3, 69.2, (24C, 24 x OCH2 TEG), 69.0 (4C, 4 x CH2 
pentaerythrit), 64.6 (4C, 4 x CH2 propargyl), 61.1 (4C, 4 x CH2 propargyl), 
50.1, 50.0 (8C, 8 x NCH2 TEG), 45.3 (1C, Cq pentaerythrit), 20.6, 20.5 
(12C, 12 x CH3 Ac), 15.7 (4C, 4 x CH3). MS (MALDI-TOF): m/z calcd for 
C109H164N24NaO48: 2600.10 [M+Na]+; found: 2600.13; elemental analysis 
calcd (%) for C109H164N24O48: C 50.77, H 6.41; found: C 50.83, H 6.49. 
Compound 18. Method I.: Azide compound 12 (85 mg, 0.07 mmol) and 
alkyne 5 (82 mg, 0.40 mmol) were reacted in CH3CN according to 
general method A. The crude product was purified by flash column 
chromatography (CH3CN/H2O 7:3) to give compound 18 (91 mg, 65%) as 
a colourless syrup. Method II.: Compound 17 (82 mg, 0.03 mmol) was 
deacetylated according to general method C. The crude product was 
purified by flash column chromatography (CH3CN/H2O 7:3) to give 
compound 18 (37 mg, 60%) as a colourless syrup. [α]24D –91.1 (c = 0.09, 
MeOH); Rf = 0.18 (CH3CN/H2O 7:3); 1H NMR (400 MHz, D2O): δ = 7.98, 
7.90 (2 x s, 8H, 8 x CH triazole), 4.91 (d, J = 3.4 Hz, 4H, 4 x H-1), 4.65 (q, 
J = 12.8 Hz, 8H, 4 x CH2 propargyl), 4.54-4.49 (m, 16H, 8 x NCH2 TEG), 
4.41 (s, 8H, 4 x CH2 propargyl), 3.87-3.83 (m, 20H, 4 x H-5, 8 x OCH2 
TEG), 3.72 (dd, J = 7.4 Hz, J = 3.3 Hz, 8H, 4 x H-2, 4 x H-3), 3.69-3.68 
(m, 4H, 4 x H-4), 3.51-3.49 (m, 16H, 8 x OCH2 TEG), 3.44-3.43 (m, 16H, 
8 x OCH2 TEG), 3.30 (s, 8H, 4 x CH2 pentaerythrit), 1.03 (d, J = 6.6 Hz, 
12H, 4 x CH3); 13C NMR (100 MHz, D2O): δ = 145.1, 145.0 (8C, 8 x Cq 
triazole), 126.2, 126.1 (8C, 8 x CH triazole), 99.5 (4C, 4 x C-1), 72.7 (4C, 
4 x C-4), 70.5 (4C, 4 x C-2), 70.6, 70.5, 70.4, 69.7 (24C, 24 x OCH2 TEG), 
69.2 (4C, 4 x CH2 pentaerythrit), 68.9 (4C, 4 x C-3), 67.7 (4C, 4 x C-5), 
64.5 (4C, 4 x CH2 propargyl), 61.6 (4C, 4 x CH2 propargyl), 51.0 (8C, 8 x 
NCH2 TEG), 45.6 (1C, Cq pentaerythrit), 16.2 (4C, 4 x CH3). MS (MALDI-
TOF): m/z calcd for C85H140N24NaO36: 2097.15 [M+Na]+; found: 2097.24; 
elemental analysis calcd (%) for C85H140N24O36: C 49.22, H 6.80; found: 
C 49.31, H 6.94. 
Compound 19. Azide compound 10 (50 mg, 0.08 mmol) and alkyne 5 
(72 mg, 0.36 mmol) were reacted in CH3CN according to general method 
A. The crude product was purified by flash column chromatography 
(CH3CN/H2O 7:3) to give compound 19 (70 mg, 71%) as a colourless 
syrup. [α]24D –67.5 (c = 0.16, H2O); Rf = 0.54 (CH3CN/H2O 7:3); 1H NMR 
(400 MHz, D2O): δ = 7.87, 7.75, 7.69 (3 x s, 6H, 6 x CH triazole), 7.16 (s, 
2H, arom.), 4.99, 4.93 (2 x s, 6H, 3 x CH2 propargyl), 4.88 (s, 8H, 4 x 
NCH2 ethylene glycol), 4.80 (s, 7H, 2 x NCH2 ethylene glycol, 3 x H-1), 
4.47 (dd, J = 27.0 Hz, J = 12.1 Hz, 6H, 3 x CH2 propargyl), 3.77 (s, 3H, 
COOCH3), 3.76-3.61 (m, 12H, 3 x H-5, 3 x H-2, 3 x H-3, 3 x H-4), 0.95 (d, 
J = 6.4 Hz, 9H, 3 x CH3) ppm; 13C NMR (100 MHz, D2O): δ = 166.6 (1C, 
COOCH3), 150.3 (2C, 2 x Cq arom.), 143.4 (6C, 6 x Cq triazole), 139.2 
(1C, Cq arom.), 124.6 (1C, Cq arom.), 124.0 (6C, 6 x CH triazole), 108.1 
(2C, arom.), 97.5 (3C, 3 x C-1), 70.9 (3C, 3 x C-4), 67.1 (3C, 3 x C-2), 
65.9 (3C, 3 x C-3), 64.1 (3C, 3 x C-5), 63.8, 60.9, 59.4 (6C, 6 x CH2 
propargyl), 52.1 (1C, COOCH3), 49.0 (6C, 6 x NCH2 ethylene glycol), 
14.4 (3C, 3 x CH3) ppm. MS (MALDI-TOF): m/z calcd for 
C50H68N18NaO20: 1263.48 [M+Na]+; found: 1263.50; elemental analysis 
calcd (%) for C50H68N18O20: C 48.38, H 5.52; found: C 48.44, H 5.61. 
Compound 20. Azide compound 14 (105 mg, 0.14 mmol) and alkyne 5 
(170 mg, 0.84 mmol) were reacted in CH3CN according to general 
method A. The crude product was purified by flash column 
chromatography (CH3CN/H2O 7:3) to give compound 20 (102 mg, 46%) 
as a colourless syrup. [α]24D –64.6 (c = 0.11, H2O); Rf = 0.29 
(CH3CN/H2O 7:3); 1H NMR (400 MHz, D2O): δ = 7.81, 7.75 (2 x s, 8H, 8 x 
CH triazole), 4.84 (s, 16H, 8 x NCH2 ethylene glycol), 4.78 (s, 4H, 4 x H-
1), 4.52 (dd, J = 28.9 Hz, J = 12.6 Hz, 8H, 4 x CH2 propargyl), 4.33 (s, 8H, 
4 x CH2 propargyl), 3.76 (d, J = 6.4 Hz, 4H, 4 x H-5), 3.64 (s, 8H, 4 x H-2, 
4 x H-3), 3.60 (s, 4H, 4 x H-4), 3.19 (s, 8H, 4 x CH2 pentaerythrit), 0.95 (d, 
J = 6.4 Hz, 12H, 4 x CH3) ppm; 13C NMR (100 MHz, D2O): δ = 145.4, 
145.2 (8C, 8 x Cq triazole), 126.1, 126.0 (8C, 8 x CH triazole), 99.4 (4C, 4 
x C-1), 72.8 (4C, 4 x C-4), 70.6 (4C, 4 x C-2), 69.4 (4C, 4 x CH2 
pentaerythrit), 69.0 (4C, 4 x C-3), 67.7 (4C, 4 x C-5), 64.4 (4C, 4 x CH2 
propargyl), 61.2 (4C, 4 x CH2 propargyl), 50.8 (8C, 8 x NCH2 ethylene 
glycol), 45.6 (1C, Cq pentaerythrit), 16.3 (4C, 4 x CH3) ppm. MS (MALDI-
TOF): m/z calcd for C61H92N24NaO24: 1567.66 [M+Na]+; found: 1567.65; 
elemental analysis calcd (%) for C61H92N24O24: C 47.41, H 6.00; found: C 
47.49, H 6.08. 
Compound 22. Azide compound 4 (180 mg, 0.75 mmol) and alkyne 5 
(101 mg, 0.50 mmol) were reacted in CH3CN according to general 
method A. The crude product was purified by flash column 
chromatography (CH2Cl2/MeOH 9:1) and the product was converted into 
azide according to general method B. The crude product was purified by 
flash column chromatography (CH2Cl2/MeOH 9:1) to give compound 22 
(77 mg, 49%) as a colourless syrup. [α]24D –132.6 (c = 0.12, H2O); Rf = 
0.38 (CH2Cl2/MeOH 85:15); 1H NMR (400 MHz, CDCl3+CD3OD): δ = 
7.91 (s, 1H, CH triazole), 4.94 (s, 1H, H-1), 4.83 (d, J = 12.6 Hz, 1H, 
CH2a propargyl), 4.67 (d, J = 12.5 Hz, 1H, CH2b propargyl), 4.57-4.54 (m, 
2H, NCH2 ethylene glycol), 3.98 (q, J = 6.5 Hz, 1H, H-5), 3.86-3.83 (m, 
2H, N3CH2 ethylene glycol), 3.78 (s, 2H, H-2, H-3), 3.71 (s, 1H, H-4), 
1.26 (d, J = 6.6 Hz, 3H, CH3) ppm; 13C NMR (100 MHz, CDCl3+CD3OD): 
δ = 144.2 (1C, Cq triazole), 123.7 (1C, CH triazole), 98.2 (1C, C-1), 71.6, 
70.0, 68.4, 66.1 (4C, C-2, C-3, C-4, C-5), 60.2 (1C, CH2 propargyl), 50.1, 
49.1 (2C, 2 x NCH2 ethylene glycol), 15.4 (1C, CH3) ppm. MS (MALDI-
TOF): m/z calcd for C11H18N6NaO5: 337.12 [M+Na]+; found: 337.26; 
elemental analysis calcd (%) for C11H18N6O5: C 42.04, H 5.77; found: C 
42.11, H 5.83. 
Compound 23. Diazide compound 21 (312 mg, 1.28 mmol) and alkyne 5 
(72 mg, 0.36 mmol) were reacted in CH3CN according to general method 
A. The crude product was purified by flash column chromatography 
(CH2Cl2/MeOH 9:1à7:3) to give compound 23 (56 mg, 35%) as a 
colourless syrup. (The dimer compound 24 was also observed). [α]24D –
87.1 (c = 0.16, H2O); Rf = 0.42 (CH2Cl2/MeOH 7:3); 1H NMR (400 MHz, 
CDCl3): δ = 7.83 (s, 1H, CH triazole), 4.94 (s, 1H, H-1), 4.79 (d, J = 12.3 
Hz, 1H, CH2a propargyl), 4.64 (d, J = 12.5 Hz, 1H, CH2b propargyl), 4.54 
(s, 2H, NCH2 TEG), 3.96-3.94 (m, 1H, H-5), 3.88-3.84 (m, 4H, OCH2 
TEG, H-2, H-3), 3.75 (s, 1H, H-4), 3.68-3.62 (m, 10H, 5 x OCH2 TEG), 
3.40-3.37 (m, 2H, N3CH2 TEG), 1.23 (d J = 6.2 Hz, 3H, CH3) ppm; 13C 
NMR (100 MHz, CDCl3): δ = 144.1 (1C, Cq triazole), 124.2 (1C, CH 
triazole), 98.5 (1C, C-1), 72.1, 70.7, 68.9, 66.5 (4C, C-2, C-3, C-4, C-5), 
70.6, 70.5, 70.1, 69.4 (6C, 6 x OCH2 TEG), 60.8 (1C, CH2 propargyl), 
50.7, 50.3 (2C, 2 x NCH2 TEG), 16.3 (1C, CH3) ppm. MS (MALDI-TOF): 
m/z calcd for C17H30N6NaO8: 469.20 [M+Na]+; found: 469.24; elemental 
analysis calcd (%) for C17H30N6O8: C 45.73, H 6.77; found: C 45.81, H 
6.88. 
Ligand preparation 
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All lyophilized ligands were dissolved in DMSO to final concentration 50 
mM and used in selected assays. 
Protein production and purification 
Protein was produced in Escherichia coli Tuner(DE3)/pET25b_phl cells 
as previously described.[5] The cells were grown in LB broth medium 
containing 100 µM ampicillin at 37 °C. When the culture reached an 
OD600 of 0.5, protein production was induced with 0.2 mM isopropyl b-D-
1-thiogalactopyranoside (IPTG, ForMedium, UK). Cells were incubated 
for an additional 20 hours at 18 °C, harvested by centrifugation at 12,000 
g for 10 min and resuspended in buffer A (20 mM Tris/HCl, 300 mM NaCl, 
pH 7.5). Harvested cells were stored at -20 °C prior to protein purification.  
Cells were then disintegrated by sonication (VCX 500, Sonics & Materials, 
Inc., USA) and the cytosolic fraction containing soluble PHL was 
collected by centrifugation at 21,000 g at 4 °C for 1 hour and filtrated 
through a 0.45 µm pore size filter (Carl Roth, Germany). Recombinant 
protein PHL was purified with isocratic elution on a d-mannose-agarose 
(Sigma-Aldrich, USA) resin equilibrated with buffer A by affinity 
chromatography using an ÄKTA FPLC system (GE Healtcare, UK). 
Purified PHL was dialyzed against appropriate buffer and used for further 
studies. 
Hemagglutination inhibition assay 
Human red blood cells (RBCs) O were processed according to previously 
published work.[5] In brief, RBCs O treated with natrium citrate were 
washed four times by PBS buffer (137 mM NaCl, 2.7 mM KCl, 8 mM 
Na2HPO4, 1.47 mM KH2PO4, pH 7.4), diluted to 50% by PBS with 
0.005% (w/w) natrium azide and treated by 0.1% papain for the duration 
of 30 minutes. IRB approval for use of these samples is not requested. 
Hemagglutination inhibition assay was performed for specificity and 
semi-quantitative affinity of the PHL interaction with the compounds. 
Chosen carbohydrate inhibitors in starting concentration from 12.5 mM to 
0.1 mM were used for determination of the lowest inhibiting concentration. 
The lectin in concentration 2 mg mL-1 was mixed with serially diluted 
carbohydrate inhibitors in a 5 µl:5 µl ratio. Subsequently, 10 µl of 10% 
RBCs O was added. The mixture was thoroughly mixed and incubated 
for 10 minutes at room temperature.[21] After incubation, mixture was 
again mixed and reaction was observed on microscope slides using 
Levenhuk 2L NG microscope with Levenhuk D2L digital camera 
(Levenhuk, USA). For obtaining images, the software ToupView for 
Windows (Levenhuk, USA) was used. The positive (PHL without 
inhibitor) and negative control (reaction without PHL) were prepared and 
processed in the same way using the appropriate volume of PBS buffer 
instead of the not included components. The lowest concentration of 
inhibitor able to inhibit agglutination was determined and compared with 
the standard (L-fucose). 
Surface plasmon resonance 
Surface plasmon resonance (SPR) experiments were performed on a 
BIAcore T200 instrument (GE Healthcare, UK) at 25 °C, using buffer A 
supplemented with 0.05 % Tween 20 as a running buffer. a-L-fucoside 
was immobilized onto CM5 sensor chip (GE Healthcare, UK) covered 
with a carboxymethylated dextran matrix. The sensor chip surface was 
activated with N-ethyl-N-(3-dimethylaminopropyl)carbodiimide/N-
hydroxysuccinimide solution and then coated with streptavidin using the 
manufacturer’s standard protocol using HBS buffer (10 mM HEPES, 150 
mM NaCl, 0.05% Tween 20, pH 7. 5). Unreacted groups were blocked 
with 1 M ethanolamine-HCl, pH 8.5. Biotinylated carbohydrate (biotin-
PAA-monosaccharides, Lectinity, Russia) was injected onto particular 
measuring channel and pure biotin on blank channel at a flow rate of 5 µl 
min-1. 
In the experimental setup, SPR inhibition measurements were carried out 
on measuring channel with L-fucosides at a flow rate of 5 µl min-1. Protein 
PHL at a concentration of 20 µg mL-1 was mixed with various 
concentrations of inhibitors (500 – 5 µM) and injected onto the sensor 
chip. The response of lectin bound to the sugar surface at equilibrium 
was plotted against the concentration of inhibitor in order to determine 
IC50 (concentration of inhibitor resulting in 50% inhibition of binding). As 
IC50 is not a constant and depends on the experimental set-up, a 
parameter called potency was used for characterization. The potency of 
a tested inhibitor is the ratio of IC50 of a chosen standard inhibitor (in this 
case L-fucose) and the inhibitor in question. Pure PHL lectin was used as 
a control (0% inhibition) and channel with pure biotin served as a blank. 
Isothermal titration calorimetry 
PHL protein in buffer A was equilibrated at room temperature at least for 
30 min before ITC measurement. All ITC experiments were performed 
using ITC200 calorimeter (Malvern Instruments Ltd., UK) at 25 °C. 
Carbohydrate ligands were dissolved in the same buffer and used at 
different concentrations. Protein in the calorimeter cell (50 µM) was 
titrated by consecutive additions (2 µl) of the ligand (1.5 – 50 mM) in the 
syringe while stirring at 1000 rpm. Control experiments (injections of 
individual ligands into the buffer A) were performed, and heat responses 
were subtracted. Integrated heat effects were analyzed by nonlinear 
regression using a single-site binding model in Origin 7 software 
(Microcal Instruments).[22] At least two independent titrations were carried 
out for each tested ligand. 
Crystallization and data collection 
PHL was concentrated to 12.5 mg mL-1 using an ultrafiltration unit with a 
10-kDa cut-off membrane (Vivaspin 20, Sartorius, Germany). The crystal 
preparation was described previously.[5] The crystals were obtained 
under the following conditions: 4 µl sitting drop, protein solution mixed 
with precipitant (3.7-4.0 M NaCl, 100 mM Hepes pH 7.5) in ratios 1:1, 3:5, 
1:3 and 1:7. The drops were set against 0.5 mL of the same equilibration 
precipitant. To determine the PHL structure complexed with ligands, the 
crystals of PHL were soaked in a 1 mM solution of compounds 16, 18, 19, 
20 for 45 minutes or 2.5 mM solution of compound 5 for 20 minutes, 
respectively. The crystals were cryo-protected using 40% PEG 400 and 
frozen in liquid nitrogen. The diffraction data of PHL complexed with 
saccharides were collected at the BESSY II electron storage ring (Berlin-
Adlershof, Germany).[23] 
Structure determination 
Images were processed using XDSAPP[24] and converted to structure 
factors using the program package CCP4 v.6.5[25], with 5% of the data 
reserved for Rfree calculation. The structure of PHL complex was solved 
by molecular replacement with MOLREP[26] using the monomeric 
coordinates of the ligand-free PHL structure (PDB ID: 5MXE). 
Refinement of the molecule was performed using REFMAC5[27] 
alternated with manual model building in Coot v.0.8.[28] Sugar-derived 
ligand coordinates were established using JLigand[29] included in CCP4 
program package. Ligand and other compounds that were present were 
placed manually using Coot. Water molecules were added by Coot and 
checked manually. The addition of alternative conformations, where 
necessary, resulted in final structure that was validated using the ADIT 
(http://rcsb.org) and MolProbity[30] (http://molprobity.biochem.duke.edu) 
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validation servers and was deposited in the PDB as entry 6F5W. 
Molecular drawings were prepared using Pymol (Schrödinger, Inc., USA). 
1H STD NMR experiment 
STD experiments were performed for samples dissolved in D2O (PBS, 
pH = 7.5, T = 298 K) with molar ratio of ligand to PHL of about 100:1. 
Protein concentration was kept as low as ca. 10 μM to avoid aggregation 
of PHL upon adding ligands. A train of band-selective E-BURP-1 shaped 
pulses of 50 ms each with a maximum B1 field strength of 90 Hz was 
employed for selective saturation of protein magnetization in total of 3 s. 
An off-resonance frequency of δ = -27 ppm and on-resonance 
frequencies of δ = −1.5 ppm for irradiation at aliphatic signal region and 
of δ = 10.5 ppm for aromatic region of PHL were applied. Off- and on-
resonance data were recorded at alternate scans and the corresponding 
FIDs were collected in separate memories for subsequent processing 
and for the generation of STD spectra. The STD intensities given in Figs. 
6. and 7. were normalized with respect to that of H-1 proton (100 %) 
obtained upon irradiating at the aliphatic signal region of protein. 
P. asymbiotica growth 
P. asymbiotica subsp. australis was inoculated from a stock cells stored 
at -80 °C into a standard LB media and were grown in 30 °C under an 
orbital shaking overnight. Bacterial growth was tracked by measuring the 
optical density of the broth at 600 nm (OD600) using a spectrophotometer 
(WPA CO8000 Biovawe Cell Density Meter, Biochrom Ltd., UK). Cells 
were harvested when reaching a OD600 = 0.5. The culture was 
centrifuged at 4,300 g and 22 °C for 2 minutes (Eppendorf centrifuge 
MiniSpin, Eppendorf, Germany) and cells were then washed three times 
by PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4). 
Cells were diluted in PBS to OD600 of 2.0 and kept in a fridge until 
performing the aggregation assay. 
Cell aggregation assay 
Fucosylated compounds were diluted in dimethylsulfoxide (DMSO) to a 
final concentration of 50mM. P. asymbiotica subsp. australis cells and 
ligands were gently mixed in a 1:1 (v/v) ratio. Ligands were diluted to a 
final concentration ranging from 25 mM to 0.3125 mM. The reaction 
mixtures were left at room temperature for 30 min. 5 µl of reaction 
mixture were then transferred onto a microscope slides. As a negative 
control, bacterial cells were mixed with DMSO in absence of fucosylated 
inhibitors to a final concentration of DMSO of 50 % at an OD600 of 1.0. 
Microscopic observation was performed at 200x magnification using an 
optical microscope (Olympus IX81 Microscope IX81F-3 with IX2-UCB-2 
Controller and X-Cite 120PC Q; Olympus, Japan and Excelitas 
Technologies, USA).   
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